| Sl.No |
Title of the projects & PI |
Funding Agency & No. |
Duration |
1 |
Tear Proteomics profile in Rheumatoid arthritis patients associated with and without Dry eye syndrome
(PI: Dr. N. Angayarkanni)
|
DBT
PR/10412/Med/30/82/08
|
3 years
(2008-2011) |
2 |
Role of LOX and Homocysteine in the aqueous humor and the plasma of patients with PXE syndrome
(PI: Dr. N. Angayarkanni)
|
ICMR
52/18/2002-BMS
|
2 years
(2009-2011) |
3. |
Investigation Into The role of lipids, BDNF and VEGF in Diabetic Retinopathy. (PI: Dr. N. Angayarkanni)
|
DBT
PR11627/MED/30/157/08
|
3 years
(2009-2012) |
4. |
Experimental study on the potential antiglycating effects of a novel mixture of amino acids on hyperglycemia induced retinal changes. (PI: Dr. N. Angayarkanni)
|
CSIR
27(0215)/09/EMR II
|
2 years
(2009-2011) |
5. |
Identifying compounds which potently inhibit MMP 2, 9: therapeutic applications for retinal diseases.
(Co-PI: Dr. N. Angayarkanni)
|
CSIR
27(0219)/09/EMR II
|
2 years
(2009-2011) |
6. |
Effects of the pesticide chloryrifos on the proteome of human retinal pigment epithelial cell line (ARPE-19). (Co-PI: Dr. N. Angayarkanni)
|
ICMR
5/8/4-18(Env)/08-NCD-I
|
2 years
(2010-2012) |
7. |
Role of adiponectin on the integrity of Blood retinal
barrier during diabetic retinopathy using an in vitro 3D
cell culture model. (PI: Dr. J. Subbulakshmi)
|
DBT (RGYI)
PR15023/GBD/27/282/10
|
3 years
(2011-2014) |
8. |
Characterization of a novel 88 kDa protein found in patients
with Eales’ disease, Uveitis, tuberculosis, leprosy and
rheumatoid arthritis (PI: Dr. K.N. Sulochana)
|
ICMR
53/9/2001
|
2 years
2011-13 |
9. |
Adiponectin as a “therapeutic target” for ocular angiogenesis (PI: Dr. K.N. Sulochana)
|
ICMR
5/4/6/6/09-NCD II |
2 years
(2010-2012) |
10. |
Development of siRNA by targeting copper regulators to control
angiogenesis (PI: Dr. K.N. Sulochana)
|
DBT
PR/2885/AGR/36/620/09 |
3 yrs
(2010-2013) |
11. |
Development of a simple fluorescent assay for serum LOX
activity (PI: Dr. K.N. Sulochana)
|
ICMR
52/6/2009-BMS |
2 yrs
(2010-2012) |
12. |
Design and development of small therapeutic peptide to target
Angiogenesis by regulating LOX (PI: Dr. K.N. Sulochana)
|
CSIR
27(0241)/10/EMR II |
3 years
2011-14 |
13. |
Studies on thiolation and homocysteinylation of serum proteins in the two retinal diseases – ARMD and ED.
(Co-PI: Dr. K.N. Sulochana)
|
ICMR
52/16/2007-BMS |
2 years
(2009-2011) |
14. |
Development of therapeutic peptides from small proteoglycan LRR family for the inhibition of tumor angiogenesis.
(PI: Dr. K.N. Sulochana)
|
DBT
PR13198/Med/30/245/09 |
2 yrs
(2011-2013) |
15. |
Investigating the therapeutic potential of LOX propeptide in angiogenesis and tumorogenesis (PI: Dr. K Coral)
|
DST FAST TRACK
No. 0071/2010 |
2 yrs
(2010-2013) |
16. |
Identification of interacting partners for PEDF in causing anti-angiogenesis ((PI:Dr.K.N. Sulochana)
|
DST
SR/SO/JS/0099/2010
3 yrs |
3 yrs |
17. |
Screening of the AMD patients for PON polymorphism and its functional correlation at the level of the PON activity, OxLDL and Homocysteine in the blood (DR. N. Angayarkanni)
|
DBT |
3 yrs |
